USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.11, $0.11 better than the analyst estimate of $1.00. Revenue for the quarter came in at $273.1 million versus the consensus estimate of $257.81 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.